Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Diabetes

Scientists have discovered why type 1 diabetes is worse for young children

Type 1 diabetes is more severe and aggressive in young children and scientists have now discovered why

The Independent UK

High blood pressure rates in children nearly doubled in 20 years, global review finds

Poor diet, inactivity and obesity believed to have caused hypertension for millions of under-19s around the world

The Guardian - UK

The common foods that increase your risk of pre-diabetes

Young people’s consumption of foods high in sodium, sugar, and unhealthy fats is increasing their risk of diabetes, a study has found

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Meghan Trainor looks unrecognisable at Baby2Baby Gala after revealing use of Mounjaro weight loss jabs

‘Where is Meghan Trainor and what did you do with her?’ joked shocked fans on social media

Evening Standard

The nut secret: 14 easy, delicious ways to eat more of these life-changing superfoods

A handful of nuts a day can help manage obesity and reduce your risk of cardiovascular disease, type 2 diabetes and some kinds of cancer. Yet most of us don’t get enough. Here’s a no-fuss guide to getting your 30g a day

The Guardian - UK

Scientists warn common diabetes drug may be cancelling out benefits of exercise

New study raises urgent questions about how doctors treat diabetes

The Independent UK

Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx

President Donald Trump on Thursday announced agreements with Eli Lilly and Co. (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) to significantly reduce prices for their GLP-1-based obesity and diabetes drugs.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

There are more than 100 autoimmune diseases, and they mostly strike women. Here's what to know

Autoimmune diseases can affect just about every part of the body – and tens of millions of people

The Independent UK

Trump says Medicare can now cover weight loss drugs like Ozempic

The pilot program could make it easier for seniors to use drugs like Wegovy and Zepbound.

Axios

Trump unveils deal to expand coverage and lower costs on obesity drugs

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy

The Independent UK

Higher-Dose Of Wegovy Demonstrates Weight Loss And Cardiovascular Benefits

At the ObesityWeek, Novo Nordisk A/S (NYSE:NVO) presented new findings from the STEP UP phase 3b trial.

Benzinga

This is the exercise you need to combat obesity and diabetes, new study says

It’s estimated that more than 5.8 million people in the UK are living with diabetes, which is an all-time high, according to Diabetes UK

The Independent UK

New food warnings could save thousands of peoples’ lives, experts say

Many countries have brought in a mandatory nutritional warning label law

The Independent UK

Child obesity crisis: London has worst record in weight surge for primary school youngsters, report reveals

More than a fifth of Year Six pupils in the capital are obese, according to new study

Evening Standard

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

London’s unhealthiest high streets revealed with seven among worst in Britain

Communities named face higher risks of obesity, diabetes and heart disease, experts say

International Business Times

LLY Stock Update: Eli Lilly Shares Hold Firm Amid Strong Earnings

Eli Lilly and Co. (NYSE: LLY) shares are trading at $813.53 on Thursday morning, inching down 0.01% after a strong run earlier this year.

The Independent UK

Scientists discover five new genes which increase obesity risk

Scientists have identified 13 genes that could increase a person’s risk of developing obesity

The Independent UK

The US obesity rate is declining thanks to weight loss drugs, survey finds

There are now 7.6 million fewer American adults living with obesity

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

New drug could help prevent sight loss in people with diabetes, study suggests

The study was led by researchers at Queen’s University Belfast.

AAP

Gender lens needed to examine weight management

Weight management for women can be impacted by a variety of biological and emotional factors, with experts saying a gender-focused approach is needed.

The Guardian - UK

NHS health checks in England to have questions on menopause for first time

Experts welcome the addition but urge the health service to improve awareness of checks in the first place

AAP

One simple change could possibly save dozens of babies

A leading diabetes expert is urging Australia to make access to a game-changing medical device easier and cheaper for those with the condition.

International Business Times UK

What Is Retatrutide? Viral Weight Loss Drug Claimed to Battle Obesity—But Is It Even Real?

Influencers are promoting the weight-loss drug Retatrutide online, but it's an unapproved medication. Learn about the dangers of fake versions and when the real drug might actually be available.

Benzinga

Trump's Weight-Loss Drug Push May Put These ETFs On A Diet

The weight-loss industry that fueled one of Wall Street’s most popular ETF themes may finally be going on a crash diet.

Benzinga

Why Hims & Hers Health Shares Are Sliding Friday

Shares of Hims Hers Health Inc (NYSE:HIMS) are trading lower Friday morning after comments from President Donald Trump indicated that he expects the prices of popular weight-loss drugs to decrease. Here’s what investors need to know.

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Exeter

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.